QT
KYMR icon

Quantamental Technologies’s Kymera Therapeutics KYMR Stock Holding History

Quantamental Technologies’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-3,256
Closed -$207K – 478
2021
Q4 		$207K Buy
+3,256
New +$190K 0.1% 326

Other funds holding KYMR

AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Quantamental Technologies's KYMR Position: Q1 2022 in Review

Quantamental Technologies sold out of Kymera Therapeutics (KYMR) in Q1 2022, closing a stake of 3,256 shares — an estimated $207K sold.

Quantamental Technologies first reported a position in KYMR in Q4 2021 and held it in 1 quarter. The position peaked at $207K in Q4 2021. 126 funds tracked by Wall St. Rank hold KYMR as of Q1 2022.

  • Quantamental Technologies reported no remaining Kymera Therapeutics position as of Q1 2022 after selling out during the quarter.
  • Quantamental Technologies sold 3,256 Kymera Therapeutics shares in Q1 2022, an estimated $207K.
  • Quantamental Technologies first reported a position in Kymera Therapeutics in Q4 2021 and held it in 1 quarter.
  • Quantamental Technologies's Kymera Therapeutics position peaked at $207K in Q4 2021.
  • 126 funds tracked by Wall St. Rank held Kymera Therapeutics as of Q1 2022.

Based on Quantamental Technologies's 13F filing for Q1 2022, filed 16 May 2022.